Herb-drug pharmacokinetic interaction between radix astragali and pioglitazone in rats

Journal of Ethnopharmacology

Volumn 144, Issue 2, 2012, Pages 300-304

  Yuan, Yue Mei ^a   Gao, Jing Wen ^a   Shi, Zhan ^a   Huang, Ping ^a   Lu, Ya Song ^b   Yao, Mei Cun ^a   Huang, Min ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b PFIZER INC   (United States)

Author keywords

Herb drug pharmacokinetic interaction; Pioglitazone; Radix astragali; Type 2 diabetes; UPLC MS MS

Indexed keywords

ASTRAGALI RADIX; HERBACEOUS AGENT; PIOGLITAZONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG CLEARANCE; DRUG HALF LIFE; DRUG STABILITY; HERB DRUG INTERACTION; MALE; MASS SPECTROMETRY; MAXIMUM PLASMA CONCENTRATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; RAT; SINGLE DRUG DOSE; TIME TO MAXIMUM PLASMA CONCENTRATION; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

ANIMALS; ASTRAGALUS PLANT; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DRUGS, CHINESE HERBAL; HERB-DRUG INTERACTIONS; HYPOGLYCEMIC AGENTS; MALE; RATS; RATS, WISTAR; THIAZOLIDINEDIONES;

RATTUS;

EID: 84868212483     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2012.09.012     Document Type: Article

References (10)

1. J. Chilcott, P. Tappenden, M.L. Jones, and J.P. Wight A systematic review of the clinical effectiveness of pioglitazone in the treatment of type 2 diabetes mellitus Clinical Therapeutics 23 2001 1792 1823
2. Chinese Pharmacopoeia Commission Pharmacopoeia of the People's Republic of China 2010 China Medical Science Press Beijing
3. FDA, 2001. Guidance for industry-bioanalytical method validation. US Department of Health and Human Service, Center for Drug Evaluation and Research Center for Veterinary Medicine.
4. FDA, 2012. FDA approves first generic actos to treat type two diabetes. US Department of Health and Human Service 〈http://www.fda.gov/NewsEvents/ Newsroom/PressAnnouncements/ucm315951.htm〉.
5. C. Hess, F. Musshoff, and B. Madea Simultaneous identification and validated quantification of 11 oral hypoglycaemic drugs in plasma by electrospray ionisation liquid chromatography-mass spectrometry Analytical and Bioanalytical Chemistry 400 2011 33 41
6. P. Masiello, C. Broca, R. Gross, M. Roye, M. Manteghetti, D. Hillaire-Buys, M. Novelli, and G. Ribes Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide Diabetes 47 1998 224 229
7. Y. Seino, K. Nanjo, N. Tajima, T. Kadowaki, A. Kashiwagi, E. Araki, C. Ito, N. Inagaki, Y. Iwamoto, M. Kasuga, T. Hanafusa, M. Haneda, and K. Ueki Report of the committee on the classification and diagnostic criteria of diabetes mellitus Journal of Diabetes Investigation 1 2010 212 228
8. M.X. Song, and M. Yang New National Traditional Chinese Medicine 2nd ed. 2002 Chinese People's Medical Publishing House Beijing
9. X. Tong The pharmacology study of active constituents from Astragalus Lishizhen Medicine and Materia Medica Research 5 2011 1246 1249
10. J. Waugh, G.M. Keating, G.L. Plosker, S. Easthope, and D.M. Robinson Spotlight on pioglitazone in type 2 diabetes mellitus Treatments in Endocrinology 5 2006 189 191